Scientists at Weill Cornell Medicine and the Burke Neurological Institute have developed a groundbreaking drug that may ...

FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review has been granted in ...

A major breakthrough in our understanding of pain has been revealed in a collaborative study, opening the door to new ways of tackling long term pain without harmful and addictive opioids.

Neuropathic pain, often caused by nerve damage or dysfunction, is a common side effect of certain chemotherapy drugs like ...

Analyst Joseph Pantginis of H.C. Wainwright maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report), retaining the price ...

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, the University of Kiel, and the Leibniz Institute of ...

A team of researchers from Weill Cornell Medicine and the Burke Neurological Institute has developed a groundbreaking drug ...

Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing ...

An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...

A summary of the joint Annual Scientific Meeting (ASM) of the Irish Pain Society (IPS) and Northern Ireland Pain Society ...